Cephalexin for Oral Suspension — Class III drug recall D-0536-2024
Ongoing recall by Bryant Ranch Prepack, Inc., reported 2024-06-12, distributed nationwide. Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Ea
| Recall number | D-0536-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bryant Ranch Prepack, Inc., Burbank, CA, United States |
| Recall initiated | 2024-05-10 |
| Classified | 2024-06-04 |
| Reported by FDA | 2024-06-12 |
| Distributed | Nationwide (US) |
| Quantity | 156 bottles |
| Reason classes | labeling |
| NDC | 63629-9204, 63629-9204-01 |
| Lot numbers | 225541, 226866, 227369, 227519, 229845, 231422, 234889 |
| Expiration dates | 2025-03-31 |
Product
Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9204-1.
Reason for recall
Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g'
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0536-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.